======= KIR3DL3 ======= == Gene Information == * **Official Symbol**: KIR3DL3 * **Official Name**: killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=115653|115653]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N743|Q8N743]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KIR3DL3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KIR3DL3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610095|Open OMIM]] == Function Summary == * **Entrez Summary**: Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several 'framework' genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the 'framework' loci that is present on all haplotypes. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: N/A |ig| No GO term information is available for this gene. \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp27|Pimelic-diphenylamide-106 0.5μM R00 exp27]]|2.11| |[[:results:exp139|Nicotinamide Riboside 100μM R03 exp139]]|2.28| ^Gene^Correlation^ |[[:human genes:r:ruvbl2|RUVBL2]]|0.408| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3210 * **Expression level (log2 read counts)**: 1.53 {{:chemogenomics:nalm6 dist.png?nolink |}}